CD8A and non-small cell lung carcinoma: In stage IV non-small-cell lung cancer (NSCLC) patients, Ye et al. showed that the number of CTCs as determined by SET-iFISH correlated negatively with that of NK cells and CD3+, CD4+, and CD4+/CD8+ lymphocytes, while positively with metastasis [29].